BMY vs MIST · P/E 17, rev $24.46B vs rev $797.0K
Bristol-Myers Squibb Company (BMY) versus Milestone Pharmaceuticals Inc (MIST) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Milestone Pharmaceuticals Inc (MIST) is a biotechnology company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported MIST revenue for 2026-06-30 was $797.0K. Net income was -$54.7M. MIST currently screens at market cap $160.6M.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. MIST currently screens at market cap $160.6M.
Not investment advice. Open the BMY and MIST stock pages for the full models.
Not investment advice.